Uptrend Under Pressure 93
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 93/100 · 7 distribution days (SPY) Sep 11 Full briefing →
View
Simple research view

IQV · IQVIA Holdings, Inc.

$257.30 +0.12% Sep 10 close
Detected setup Cup & Handle · Setup Score 55/100

Stand aside — setup invalidated

Setup score 55, but distribution days reach 5 or more — stand aside until the condition resets.

Ask about IQV

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$IQV

IQVIA Holdings, Inc.

IQVIA Holdings, Inc. is a Biotechnology company in the Health Technology sector.

Health Technology Biotechnology stock Stage 2 · Advancing Base 1
$257.30 latest close
Verdict · setup score 55/100 · data Sep 10 close · 1 session old

Stand aside — setup invalidated

Setup score 55, but distribution days reach 5 or more — stand aside until the condition resets.

Earnings

Normal technical setup

Next earnings Monday, October 26, 2026 Before market open Exact clock time not supplied by source

Deterministic evidence

IQV+0.12%
Sector proxy · XLV-0.55%
Broad market · SPY-0.60%
Same completed session window ending 2026-09-10. IQV was +0.67 points vs XLV. +0.72 points vs SPY.

Session internals Strong momentum

Rule: closed up, at or above the open, in the top third of the day's range. Judged on internals, not on the size of the move.

Vs prior close+0.12% From the open+1.07% Range position75% GapNo gap
QQQ confirmationDiverging (-1.06%) SMH confirmationDiverging (-2.44%)
Short-term conviction -1 points.
  • QQQ, SMH moved against the stock — no index confirmation.
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $257.30 +0.1% Sep 10 close
52W High $271.80 5.3% below high
Wks Since High 0w
Base Depth 7.1%
RS Rank 80 percentile of scan
SMA 50 $234.05
Avg Vol 1,365,204
Rel Vol (Sep 10) 0.97×
More stats
52W Low $154.50
Tight Wks 0
Base B1
SMA 200 $202.50
RS Line vs High -4.2%
RS Line Slope +9.4% ▲
Group Rank #15/58
ADR% 2.8%
ATR(14) $6.74 (2.6%)
Vol Pace (live) N/A
U/D Vol 2.71
A/D Days 13A / 9D
A/D Rating A
VDU Bars 0/10 d
Power Trend 30d
Earnings in 44d
Position in 52-week range 88thpercentile of the 52-week range
$154.50low
$271.80high

IQV Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for IQV.

Create Free Account

Technical Analysis Report Card

$IQV · $257.30 · as of 2026-09-10 · multi-factor read
94
/ 100
Technicals 94/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▲ Uptrend
Weekly ▲ Uptrend
Monthly ▲ Uptrend

Moving Averages

50-day$234.05 ↑
100-day$204.44 ↑
200-day$202.50 ↑
Bullish (50 > 200)

RSI (14)

Reading57.1 · Bullish

Bullish momentum — comfortably in buyer territory.

MACD (12/26/9)

StateWeakening
Histogram-1.869

Weakening — MACD slipped below its signal line. Histogram contracting.

Bollinger Bands (20,2)

%B / Width53% · 14.9%

Mid-band — no directional band edge in play.

Volume · Buyer vs Seller

Up/Down vol2.71 · Accumulation
Rel volume0.97×

Accumulation — volume is concentrated on up days; buyers dominate. Recent volume is easing versus its baseline.

Support & Resistance

R · $271.8052-week high
Price · $257.30now
S · $233.76swing level
S · $227.15swing level
S · $197.60swing level

Fibonacci · Uptrend swing

23.6%$244.12
38.2%$226.99
50.0%$213.15
61.8%$199.31
78.6%$179.60

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for IQV — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Daily uptrendWeekly uptrendMonthly uptrendAbove 200-day MA50/200 bullishVolume accumulation
Want this read in a legend's voice? Ask a Legend about IQV
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 4 of 6 legends are Watching — building, not yet a confirmed buy.
Avoid
Minervini B

Trend-template read: fails 150-day MA > 200-day MA.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $257.30, MA150 $193.39, MA200 $202.50
1.4 50-day MA > 150-day MA AND 200-day MAMA50 $234.05, MA150 $193.39, MA200 $202.50
Failing evidence
1.2 150-day MA > 200-day MAMA150 $193.39 vs MA200 $202.50
2. Quarterly EPS growth ≥ 25%From SEPA scan
9/12 checks
Avoid
O'Neil D

CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 84
A: Annual earnings & revenue qualityRev +41.6%
Failing evidence
C: Quarterly EPS acceleration ≥ 25%CANSLIM grade N/A
S: Volume ≥ 40% above average on breakoutVolume ratio 0.97x
4/8 checks
Watch
Weinstein B

Stage-analysis read: Stage 2 is present; 1 supporting checks need improvement.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $257.30 vs MA200 $202.50
Failing evidence
Volume expansion above averageVolume ratio 0.97x
6/7 checks
Watch
Livermore B

Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$257.30
Relative strengthRS 84
Failing evidence
Volume vs average0.97x
Pivotal point cleared on expanding volumeNot confirmed
4/6 checks
Watch
Darvas B

Box-theory read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$257.30
Relative strengthRS 84
Failing evidence
Volume vs average0.97x
Box top broken on heavy volumeNot confirmed
4/6 checks
Watch
Wyckoff B

Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$257.30
Relative strengthRS 84
Failing evidence
Volume vs average0.97x
Sign of Strength confirmed on expanding volumePrice hasn't cleared the pivot yet — confirmation pending
4/6 checks
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Latest candle: Bullish Engulfing — Today's up candle fully engulfs yesterday's down candle — a classic bullish reversal, strongest after a pullback to support.

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising
120RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +5 A
A: 16 D: 11 Net: +565 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 4/7 met
B 4/7 criteria
Separate score from the Minervini Trend Template (7/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ
Revenue growth ≥20% YoY +42%
Gross margin ≥30%
ROE ≥17%
RS rating ≥80 (leadership) 84
Stage 2 uptrend (Weinstein) Stage 2
Within 25% of 52W high -5.3%

Method Playbook

Trade it like Wyckoff EXACT LEVELS · PRO
Wyckoff B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use the Spring/test, Sign of Strength, creek, or Last Point of Support boundary identified by the active structure.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a completed test or Sign of Strength/Last Point of Support confirmation with improving demand versus supply.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start below the Spring/test low or structural support whose failure would invalidate the accumulation read.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Raise protection beneath successive Last Points of Support or meaningful higher lows during markup; never loosen it.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit on a failed Sign of Strength, support loss, or clear supply-dominant reversal such as an upthrust failure.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Pattern Analysis

Cup & Handle Historical replay: +20% before −8% within 40 sessions: 21% (n=53) · source bars 2025-03-17–2026-09-04 · avg +1.9% per setup (+0.24R) ⚠ Not actionable yet
55 setup score
RS Score 84
Trend template 7/8
CANSLIM (N/A)
20.6% cup depth 7.1% handle
Why This Setup?
cup handle Cup & Handle · schematic

depth=20.6%, handle_pb=7.1%, lips_diff=6.6%, upper_half=yes, u_shape=yes, near_pivot=no, orderly=yes | Strong trend (7/8) | Top RS (84) | Moderate pattern (65%) | Accumulation (2.7× up/dn vol) | Power Trend | Stage 2 | Readiness 60/100 (early) | CANSLIM N/A (N/A) | ⚠ Not actionable yet

The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

3/7 universals met
  • Risk is defined — not met No stop — undefined risk
  • Asymmetric reward — partly met No target set
  • Not chasing (in range) — partly met Pivot distance unknown
  • Volume confirms — partly met 1.0× average — light
  • A relative-strength leader — met RS rank 80
  • Clear of earnings — met in 44 days
  • In a confirmed uptrend — met Stage 2 · Trend template 7/8
Why these seven? → The Universal Edge

Minervini Trend Template

7/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $257.30 vs SMA150 $193.39 / SMA200 $202.50
SMA 150 above SMA 200 SMA150 $193.39 vs SMA200 $202.50
SMA 200 trending up Slope +3.99 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $234.05
Price above SMA 50 $257.30 vs SMA50 $234.05
30%+ above 52-week low +66.5% from $154.50
Within 25% of 52-week high -5.3% from $271.80
RS score above 70 RS 84

Fundamentals

52W Range
88%
Rev YoY
+42%

Company

Company profile
IQVIA Holdings, Inc.
IQV · NYSE · Health Technology · Biotechnology
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
N/A — CANSLIM
C · Curr. EPS
100
A · Annual EPS
100
N · New Highs
100
S · Supply/Demand
70
L · Leader RS
84
I · Inst. Spons.
100
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
7/8
W. RS
100
W. Support
$154.50
W. Resist
$271.80
Weekly Structure

Scan History

20× streak
Sep 09: 88 (Base Breakout)Sep 09: 88 (Base Breakout)Sep 10: 55 (Cup & Handle)Sep 10: 55 (Wyckoff SOS)Sep 11: 55 (Cup & Handle)55
Sep 11
Cup & Handle ✓ Gate
55
Sep 10
Wyckoff SOS ✓ Gate
55 0.0%
Sep 10
Cup & Handle ✓ Gate
55 0.0%
Sep 09
Base Breakout ✓ Gate
88 +0.1%
Sep 09
Base Breakout ✓ Gate
88 +0.1%

Get the full picture on IQV

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial